Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Vigabatrin is effective for treating alcohol withdrawal syndrome

July 22, 1998

Analgesic effects of dosulepin in patients with cancer-related pain

July 22, 1998

New indication explored for established anticonvulsant

July 21, 1998

Celgene cleared to market Thalomid in U.S.

July 20, 1998

One-year trial shows efficacy of lamivudine for treatment for chronic hepatitis B

July 20, 1998

New peristaltic stimulant on the way to market in Japan

July 9, 1998

Roberts and RiboGene sign development and marketing agreement for Emitasol

July 8, 1998

Granocyte granted expanded marketing authorization

July 7, 1998

Scientifically tested hair loss treatment introduced in Canada

July 1, 1998

Broadened use of Taxotere in breast cancer cleared by FDA

June 25, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...